 |
|
|
|||||
On Monday, Alembic Pharmaceuticals saw a surge in its stock prices after the USFDA greenlit its Diltiazem Hydrochloride Tablets, a crucial treatment for high blood pressure and angina. This pivotal approval brings the company's total USFDA ANDA approvals to an impressive 230, highlighting its strong position in the pharmaceutical market.
Category:
News and Media
In the Nifty500 pack, 11 stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on November 14, 2025, according to stockedge.com's technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a look:
Category:
News and Media
Gold prices edged higher as investors awaited key U.S. economic data this week, including nonfarm payrolls, for clues on the Federal Reserve's interest rate path. Traders are now pricing in a lower probability of a rate cut next month, while a firm dollar and subdued physical demand weighed on the precious metal.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||